Product
TBI-1301
2 clinical trials
8 indications
Indication
Synovial SarcomaIndication
NY-ESO-1 Expressing Solid TumorsIndication
MelanomaIndication
Esophageal cancerIndication
Ovarian CancerIndication
lung cancerIndication
Bladder CancerIndication
Liver CancerClinical trial
Multi-center Phase I/II Study of NY-ESO-1 T Cell Receptor Gene Transferred T Lymphocytes in Patients With Synovial SarcomaStatus: Completed, Estimated PCD: 2020-01-23
Clinical trial
Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-09-01